Drug Shortage Report for MYCOBUTIN

Last updated on 2025-05-02 History
Report ID 249824
Drug Identification Number 02063786
Brand name MYCOBUTIN
Common or Proper name MYCOBUTIN
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) RIFABUTIN
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1x100 BTL
ATC code J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-05-01
Estimated end date 2025-05-28
Actual end date
Shortage status Actual shortage
Updated date 2025-05-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2025-05-02 English Compare
v8 2025-05-01 French Compare
v7 2025-05-01 English Compare
v6 2025-05-01 English Compare
v5 2025-04-02 French Compare
v4 2025-04-02 English Compare
v3 2025-04-01 English Compare
v2 2025-02-07 French Compare
v1 2025-02-07 English Compare

Showing 1 to 9 of 9